Automated Annotation of Epileptiform Burden and Its Association with Outcomes
Sahar F Zafar1, Eric S Rosenthal1, Jin Jing1
1Department of Neurology, Massachusetts General Hospital, Boston, MA.
Annals of Neurology
|July 7, 2021
Summary
Higher epileptiform activity burden in acutely ill patients is linked to poorer outcomes. This study quantifies this association, highlighting peak epileptiform activity as a key predictor of adverse events.
Area of Science:
- Neuroscience
- Clinical Neurology
- Medical Informatics
Background:
- Epileptiform activity is a common finding in acutely ill patients, but its precise impact on outcomes is not fully understood.
- Quantifying epileptiform activity burden has been challenging due to the complexity of electroencephalography (EEG) data.
Purpose of the Study:
- To determine the dose-response relationship between epileptiform activity burden and clinical outcomes in acutely ill patients.
- To establish peak epileptiform activity burden as a quantifiable predictor of patient outcomes.
Main Methods:
- Retrospective analysis of 1,967 patients with >16 hours of continuous EEG monitoring.
- Development of an artificial intelligence algorithm to quantify epileptiform activity burden from large EEG datasets.
- Machine learning models used to assess the association between epileptiform burden and modified Rankin Scale (mRS) at discharge.
Main Results:
- Peak epileptiform activity burden was independently associated with poor outcomes (mRS 5-6) (p < 0.0001).
- An increase in peak epileptiform activity burden from 0% to 100% increased the probability of a poor outcome by 35%.
- Other independent predictors of poor outcome included age, APACHE II score, seizure on presentation, and hypoxic-ischemic encephalopathy.
Conclusions:
- Automated measurement of peak epileptiform activity burden provides a consistent and quantifiable metric.
- This metric serves as a valuable target for future clinical trials investigating interventions to suppress epileptiform activity.
- Findings support the clinical significance of quantifying epileptiform activity burden for predicting patient outcomes.
More Related Videos
09:32Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
12.6K
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
3.0K
Related Concept Videos
Epilepsy and Seizures: Overview
505
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
505
Seizures: Classification
824
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
824
